Two
studies: Different results, different corporate sponsors
Expert
is leading discussion on ethical, moral issues of stem cells
Nothing like a room full of brainiacs to make a
columnist feel
small
New software helps exercise, tune up flabby,
forgetful brains
Biotech industry grappling with question of who
pays for what
Outsourcing not out of question for Bay Area
biotech companies
Breast cancer group questions value of pink ribbon
campaigns
Fresh air is hard to come by when the window won't
open
Biotech's cost-price dilemma devolves into talk of
design
Biotech industry cries foul over NYSE postponing
LSR's listing
It's both the big and little things we need to get
right in
flu fight
California medical schools to stop their cadavers
from
wandering off
Buck chief's high-protein diet helps institute to
muscle up
Personalized medicine could be antidote to soaring
care costs
Exit strategies put biotech firms between rock and
a hard
place
Breathing new life: Emerging field could offer
scientists
building blocks for new forms of life
When companies leave, state needs to ask the right
question
High times: Cal Pacific tests marijuana's
cancer-killing
potential
Making monoclonal antibodies -- not soup -- out of
chickens
|
